Condition
Non-Small Cell Lung Cancer|Small Cell Lung Cancer|Extrapulmonary Small Cell Cancer|Pulmonary Neuroendocrine Tumors|Thymic Epithelial Tumors
Estimated Enrollment: 2000
Age Group: 18 Years to 100 Years (Adult, Senior)
Gender: All
Study Type: Observational
Study Design Allocation: Observational Model: Cohort|Time Perspective: Prospective
Study ID Numbers: 140105|14-C-0105
Study First Received: May 8, 2014
Last Updated: April 20, 2017
Estimated Primary Completion Date: April 30, 2024
Primary Outcome Measures:
Allow sample acquisition for use in the study of thoracic malignancies except mesothelioma.|Follow the natural history of patients with thoracic malignancies.|Conduct genomic, proteomic and immunological analyses on blood, tumor, body fluid and normal tissue in support of NIH translational trials to develop new therapeutic agents and novel treatment approaches as well as new prognostic and diagnostic …
Sponsors and Collaborators:
National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
Website Link: https://ClinicalTrials.gov/show/NCT02146170
